vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and GETTY REALTY CORP (GTY). Click either name above to swap in a different company.

GETTY REALTY CORP is the larger business by last-quarter revenue ($57.8M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). GETTY REALTY CORP runs the higher net margin — 46.0% vs -19.9%, a 66.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 10.5%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 7.6%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Getty Realty Corp is a publicly traded real estate investment trust (REIT) headquartered in the United States. It owns, leases, and manages a diversified portfolio of commercial real estate assets, primarily consisting of convenience stores, fuel stations, and adjacent retail locations across U.S. states, serving tenants across retail and energy sectors.

ABCL vs GTY — Head-to-Head

Bigger by revenue
GTY
GTY
1.3× larger
GTY
$57.8M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+777.8% gap
ABCL
788.4%
10.5%
GTY
Higher net margin
GTY
GTY
66.0% more per $
GTY
46.0%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
7.6%
GTY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABCL
ABCL
GTY
GTY
Revenue
$44.9M
$57.8M
Net Profit
$-8.9M
$26.6M
Gross Margin
Operating Margin
-63.7%
66.1%
Net Margin
-19.9%
46.0%
Revenue YoY
788.4%
10.5%
Net Profit YoY
73.9%
80.1%
EPS (diluted)
$-0.03
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
GTY
GTY
Q1 26
$57.8M
Q4 25
$44.9M
$60.5M
Q3 25
$9.0M
$55.6M
Q2 25
$17.1M
$53.3M
Q1 25
$4.2M
$52.3M
Q4 24
$5.0M
$53.0M
Q3 24
$6.5M
$51.5M
Q2 24
$7.3M
$49.9M
Net Profit
ABCL
ABCL
GTY
GTY
Q1 26
$26.6M
Q4 25
$-8.9M
$27.0M
Q3 25
$-57.1M
$23.3M
Q2 25
$-34.7M
$14.0M
Q1 25
$-45.6M
$14.8M
Q4 24
$22.3M
Q3 24
$-51.1M
$15.3M
Q2 24
$-36.9M
$16.7M
Operating Margin
ABCL
ABCL
GTY
GTY
Q1 26
66.1%
Q4 25
-63.7%
67.3%
Q3 25
-851.8%
62.5%
Q2 25
-290.2%
46.7%
Q1 25
-1479.6%
50.5%
Q4 24
61.6%
Q3 24
-1439.4%
48.9%
Q2 24
-1276.2%
52.5%
Net Margin
ABCL
ABCL
GTY
GTY
Q1 26
46.0%
Q4 25
-19.9%
44.7%
Q3 25
-637.8%
42.0%
Q2 25
-203.3%
26.3%
Q1 25
-1077.2%
28.3%
Q4 24
42.1%
Q3 24
-785.4%
29.8%
Q2 24
-504.3%
33.5%
EPS (diluted)
ABCL
ABCL
GTY
GTY
Q1 26
$0.43
Q4 25
$-0.03
$0.46
Q3 25
$-0.19
$0.40
Q2 25
$-0.12
$0.24
Q1 25
$-0.15
$0.25
Q4 24
$0.38
Q3 24
$-0.17
$0.27
Q2 24
$-0.13
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
GTY
GTY
Cash + ST InvestmentsLiquidity on hand
$128.5M
$3.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
Total Assets
$1.4B
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
GTY
GTY
Q1 26
$3.7M
Q4 25
$128.5M
$8.4M
Q3 25
$83.2M
$5.2M
Q2 25
$92.4M
$7.5M
Q1 25
$159.3M
$6.3M
Q4 24
$156.3M
$9.5M
Q3 24
$126.6M
$4.0M
Q2 24
$148.3M
$4.7M
Total Debt
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
$995.0M
Q3 25
$934.6M
Q2 25
$919.2M
Q1 25
$901.4M
Q4 24
$904.3M
Q3 24
$833.9M
Q2 24
$838.4M
Stockholders' Equity
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
$966.9M
$1.1B
Q3 25
$964.0M
$1.0B
Q2 25
$1.0B
$982.4M
Q1 25
$1.0B
$961.1M
Q4 24
$1.1B
$962.1M
Q3 24
$1.1B
$963.4M
Q2 24
$1.1B
$951.0M
Total Assets
ABCL
ABCL
GTY
GTY
Q1 26
$2.2B
Q4 25
$1.4B
$2.2B
Q3 25
$1.4B
$2.1B
Q2 25
$1.4B
$2.0B
Q1 25
$1.3B
$2.0B
Q4 24
$1.4B
$2.0B
Q3 24
$1.4B
$1.9B
Q2 24
$1.4B
$1.9B
Debt / Equity
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
0.93×
Q3 25
0.92×
Q2 25
0.94×
Q1 25
0.94×
Q4 24
0.94×
Q3 24
0.87×
Q2 24
0.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
GTY
GTY
Operating Cash FlowLast quarter
$-34.7M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
$-34.7M
$127.4M
Q3 25
$-52.6M
$30.5M
Q2 25
$-32.4M
$34.7M
Q1 25
$-11.6M
$28.7M
Q4 24
$-108.6M
$130.5M
Q3 24
$-28.9M
$34.6M
Q2 24
$-30.0M
$29.7M
Free Cash Flow
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
$-44.6M
$127.0M
Q3 25
$-61.5M
$30.4M
Q2 25
$-45.8M
$34.6M
Q1 25
$-22.2M
$28.6M
Q4 24
$-187.0M
$129.6M
Q3 24
$-47.4M
$34.4M
Q2 24
$-50.1M
$29.6M
FCF Margin
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
-99.4%
209.8%
Q3 25
-687.0%
54.7%
Q2 25
-267.9%
64.9%
Q1 25
-524.0%
54.7%
Q4 24
-3702.8%
244.5%
Q3 24
-728.4%
66.9%
Q2 24
-683.8%
59.2%
Capex Intensity
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
21.9%
0.7%
Q3 25
99.7%
0.2%
Q2 25
78.2%
0.3%
Q1 25
251.1%
0.1%
Q4 24
1552.7%
1.7%
Q3 24
284.6%
0.4%
Q2 24
274.6%
0.3%
Cash Conversion
ABCL
ABCL
GTY
GTY
Q1 26
Q4 25
4.71×
Q3 25
1.31×
Q2 25
2.48×
Q1 25
1.94×
Q4 24
5.85×
Q3 24
2.26×
Q2 24
1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons